{"lastClose": 1.8300000429153442, "len": 457, "date": "2023-02-08", "alpha_1": -0.5584842858310958, "beta_1": 2.4981927832623096, "drawup_1": 0.6999999674883763, "natr_1": 25.221933828873134, "sup_1": -0.4098360776765977, "res_1": 0.2568305672761735, "bullPattern_1": [], "bearPattern_1": ["CLOSINGMARUBOZU"], "rsi_1": 52.96442851636748, "adx_1": 43.27580319264391, "drawdown_1": -0.7419354812594492, "stratHoldSharpe_1": -0.6438847601813408, "stratHoldAlpha_1": 250.45166755191775, "stratHoldDrawdown_1": -0.6733436006664324, "alpha_3mo": -0.517139603725252, "beta_3mo": 2.716316554251954, "drawup_3mo": 0.44078952940877514, "natr_3mo": 25.221933828873134, "sup_3mo": -0.0418943775754173, "res_3mo": 0.12386151059793359, "bullPattern_3mo": [], "bearPattern_3mo": ["LONGLINE"], "rsi_3mo": 55.714288390412435, "adx_3mo": 46.42926393049988, "drawdown_3mo": -0.4666666555125807, "stratHoldSharpe_3mo": -1.8644661559055535, "stratHoldAlpha_3mo": 249.61629227473065, "stratHoldDrawdown_3mo": -0.4199999899613227, "Country": "United States", "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "Name": "Ginkgo Bioworks Holdings Inc. Class A", "IPO Year": 2021.0, "Sector": "Health Care", "Market Cap": 3757794516, "alpha%_1": 0.06951151106108074, "beta%_1": 0.9983263891928899, "drawup%_1": 0.6539206806445145, "natr%_1": 1.0, "drawdown%_1": 0.038658569781918554, "stratHoldSharpe%_1": 0.13430728856839041, "stratHoldAlpha%_1": 0.009966193928117446, "stratHoldDrawdown%_1": 0.041259935854630475, "alpha%_3mo": 0.11857242346217611, "beta%_3mo": 0.9981567434546604, "drawup%_3mo": 0.8580956404453153, "natr%_3mo": 1.0, "drawdown%_3mo": 0.00029542444486924634, "stratHoldSharpe%_3mo": 0.04259913651448459, "stratHoldAlpha%_3mo": 0.0006868026751024009, "stratHoldDrawdown%_3mo": 0.0003426437226439045}